4: Statement of changes in beneficial ownership of securities-Director HEYER ANDREW R

Mar 19 20:27 ET

4: Statement of changes in beneficial ownership of securities-Officer Christensen Bret

Mar 18 19:46 ET

4: Statement of changes in beneficial ownership of securities-Director Cone Stephen Mark

Mar 18 19:45 ET

4: Statement of changes in beneficial ownership of securities-Director Beer Marc D

Mar 18 19:44 ET

SCHEDULE 13G/A: Others

Mar 18 13:38 ET

4: Statement of changes in beneficial ownership of securities-10% Owner Guines LLC

Mar 17 18:03 ET

8-K: Current report

Mar 17 08:06 ET

10-K: FY2024 Annual Report

Mar 14 16:05 ET

8-K: Biote Reports Fourth Quarter and Full Year 2024 Financial Results Strengthened business with launch of BioteRx and enhancements to Biote Method Provides fiscal 2025 outlook

Mar 12 16:20 ET

4: Statement of changes in beneficial ownership of securities-Officer Christensen Bret

Mar 3 19:23 ET

3: Initial statement of beneficial ownership of securities-Officer Christensen Bret

Feb 7 16:32 ET

8-K: Current report

Jan 30 16:46 ET

424B3: Prospectus

Nov 13, 2024 12:33 ET

10-Q: Q3 2024 Earnings Report

Nov 12, 2024 17:22 ET

8-K: Biote Reports Third Quarter 2024 Financial Results Continued Profitable Growth Vertical integration drives gross profit margin improvement Launch of proprietary clinical decision support software to strengthen competitive advantages

Nov 12, 2024 16:26 ET

SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-BANDERA PARTNERS LLC(7.5%),GREGORY BYLINSKY(7.5%), etc.

Nov 12, 2024 16:21 ET

SC 13G: Statement of acquisition of beneficial ownership by individuals-BlackRock, Inc.(5.3%)

Nov 8, 2024 22:18 ET

SC 13G: Statement of acquisition of beneficial ownership by individuals-BlackRock, Inc.(5.3%)

Oct 22, 2024 18:08 ET

4: Statement of changes in beneficial ownership of securities-Officer Peterson Robert Charles

Sep 11, 2024 15:36 ET

424B3: Prospectus

Aug 9, 2024 14:57 ET